Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) FCF Margin (2017 - 2025)

Organogenesis Holdings has reported FCF Margin over the past 9 years, most recently at 15.41% for Q4 2025.

  • Quarterly results put FCF Margin at 15.41% for Q4 2025, up 943.0% from a year ago — trailing twelve months through Dec 2025 was 4.34% (down 520.0% YoY), and the annual figure for FY2025 was 4.34%, down 520.0%.
  • FCF Margin for Q4 2025 was 15.41% at Organogenesis Holdings, up from 0.56% in the prior quarter.
  • Over the last five years, FCF Margin for ORGO hit a ceiling of 31.43% in Q4 2021 and a floor of 36.15% in Q2 2025.
  • Median FCF Margin over the past 5 years was 3.21% (2024), compared with a mean of 0.12%.
  • Biggest five-year swings in FCF Margin: skyrocketed 3330bps in 2021 and later crashed -4922bps in 2022.
  • Organogenesis Holdings' FCF Margin stood at 31.43% in 2021, then crashed by -157bps to 17.79% in 2022, then soared by 141bps to 7.32% in 2023, then dropped by -18bps to 5.98% in 2024, then skyrocketed by 158bps to 15.41% in 2025.
  • The last three reported values for FCF Margin were 15.41% (Q4 2025), 0.56% (Q3 2025), and 36.15% (Q2 2025) per Business Quant data.